NCT00904475 - Pilot Study of the Efficacy and Safety of Lidoderm Patch in the Treatment of Low Back Pain | Biotech Hunter

Enrollment

102

Participants

Timeline

Start Date

April 30, 2003

Primary Completion Date

April 30, 2003

Conditions

Chronic Low Back Pain

Interventions

DRUG

Lidoderm®

Eligible patients were randomized equally to one of two groups: lidocaine patch 5% or matching placebo patch. During the 6-week treatment period, patients used up to three patches daily applied q24h.

DRUG

Lidoderm®

Eligible patients were randomized equally to one of two groups: lidocaine patch 5% or matching placebo patch. During the 6-week treatment period, patients used up to three patches daily applied q24h.

Trial Locations (6)

Unknown

Birmingham

Hueytown

Phoenix

Mill Valley

Allentown

Salt Lake City